Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If I type OXYS into the search bar with my broker I get the following:
ITOX IIOT OXYS INC COM
I’m not sure if this means anything.
I think the mm's did something illegal back when $oxys was at .10 and everyone was waiting on the short squeeze. All of a sudden it just dropped to zeroes and stayed that way for 5 to 10 minutes. Like they were trying to scare people from holding. I've never seen a stock more prime for the squeeze and it never happened! If you've noticed lately, past couple months anyways, the mm's have been having their way! Like they're overdoing it. Something hasn't been right lately and it needs to be investigated.
Same here. I also have E-trade. If you google OXYS, like CNN financials doesn't have anything from them since the 25th. Kind of worried a bit here.
So when I log into my account, all of a sudden OXYS shows -100%, and the stock id is removed from etrade....and it says all my money is gone. Anybody know what happened or if this is just a glitch? I cannot find anything regarding it....
I believe $oxys will make me a lot of money the longer I hold it. It's going to be up and down. This is oxygen powder! Very convenient for all hospitals. It's going to go up! Imo
$oxys ain't going nowhere. Their next move will be much higher than the last.imo I'm buying on these lows and won't sell on their next rise.
I am wondering the same. I’m down a large chunk of change. Does anyone have any news?
Vantage Investment Advisors
Any idea on what private equity group purchased oxysure? I picked this up today from Julian Ross's linked in account
• Raised over $25 million for the company and grew it at an average of 804% per annum until it was sold to a private equity group in an asset sale in late 2016.
Yeah ...just as soon as you make pickup another 500,000 shares still!
Don't worry. It'll come back up to this hell.
Yeah ...it has gone to hell real fast!
Doesn't look positive for the short term.
They blasted it all the way down to 2 cents! Who do you think did that Earl?
I don't see much fear in the MM's based on yesterday's results.
mm's Showing their fear of the potential in oxys.
CDEL is doing a lot of buying on the bid side this morning.
OXYS is sitting right above it 100 sma.
All the indicators say this is in a very over sold situation right now. I wish I had bought at this level but thankfully I think we get a good run up from here on out.
Thank you! I’ll stay with it and buy some more.
The MM's are intentionally shorting this stock to get people to give up on the stock. Basically, they messed up so they artificially make it look like everyone is selling. The problem is that it only works if investors sell their stock. If we don't, buys should explode due to the ridiculously low prices. By holding, and being patient, the stock skyrockets. MM's have the ability to manipulate prices and they only do it to this extent when they really messed up. In my opinion, this is happening. Rarely do they do it to this extent and that's only when they're desperate. But this all depends on us.
Could you specify what you mean? I’m new to this and this one has me scared. Over half my investment into this stock is gone.
When this blows it's going to be epic! MM's are scared to death! Going way toooo far with this one!
Yes, it isn't a terrible company and I am hopeful that it will go back up also.
just ride the wave, they will get bored and it will go back up
thankfully it isn't a terrible company so we don't have much to worry about, just losing time really
Once again MM's manipulating OXYS buying at the bid ...at this rate the price will struggle to make any upward progress. When they can cover their own asses by buying at the bid they create a can't lose situation for themselves.
Good volume, not a lot of shares selling, so far.
I am with you Earl.
exaggerated a little! Wish I could! Excited w what I got though!!!
What gives you reason to believe this? Asking for a friend.
I'll be tickled if you are right!
time to load up more its going to burst soon
its almost on the verge of starting second leg up
They are selling to themselves on the bid (the lower price). Essentially they shorted the stock about 10 days ago. Now they have to cover. So they short the stock again to cover the short that is coming due. It resets the clock for them, but... it will come due again in 10 days. That is the next leg I was referencing. This pps will bounce up as all the MMs cover and we will have a new pps level that will eventually need to cover.
I'm new at this ...why don't they have to buy at the "ask" price?
That’s why I think we have another leg after this one. They are shorting today to cover tigers shorts from two weeks ago.
Waiting on the pop, it should be a good one ... hopefully their predictions are accurate
Watching CDEL on Level 2 ...it has started!
Followers
|
34
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1154
|
Created
|
01/16/13
|
Type
|
Free
|
Moderators |
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy--to-use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which is designed to make the provision of emergency oxygen safer, more accessible, and easier to use than traditional oxygen provision systems.
OXYS' products improve access to emergency oxygen that affects the survival, recovery, and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory, or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments.
OXYS manufactures its products at a manufacturing facility in Frisco, Texas. The product has also been deployed in several other countries, including Brazil, Israel, Turkey and South Africa.
Investment Highlights
Media Coverage
Products
OXYS has developed a unique platform technology whereby medically pure oxygen is created instantly from two dry inert powders, allowing oxygen to be delivered on demand. Using this technology, the company has developed the OxySure Model 615.
With Model 615, there are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training. The technology is both safe and easy-to-use for the layperson and is available over the counter. Like an AED or fire extinguisher, Model 615 can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.
(1. Plug in the Mask 2. Turn the Knob 3. Place the mask over the nose and mouth)
There is no storage of oxygen; the oxygen is created on demand. As a result, the Model 615 eliminates the dangers traditionally associated with compressed tanks.
Other unique characteristics:
Product Selling Points
OXYS’ Model 615 is a pioneering technology that is defining a new market with no direct competition, providing a solution to problems with existing emergency oxygen, such as:
Compressed Cylinders
Chemical Generators
Enormous Markets
OXYS is targeting enormous end markets that are at least as large as the install base for AEDs, which exceeds 2 million units, and potentially as large as the fire extinguisher base, which exceeds 100 million units in the U.S. (500+ million units globally).
Already Approved
Model 615 has already been cleared by the U.S. Food & Drug Administration for over-the-counter (OTC) sale without the need for a prescription, and is already in the commercialization phase.
Recurring Revenue Model
Model 615 consists of a reusable housing and a replaceable cartridge, which must be replaced after each use or upon expiry of a 2-year shelf life. Over time, this results in recurring revenues and greater earnings predictability.
Future products
OXYS’ “oxygen from powder” technology also allows the company to develop much needed solutions for other vertical markets such as aviation, mining, and sports & recreation markets.
Market Opportunity
OXYS has been primarily focused on establishing partnerships with distributors, as well as reaching out to large OEM customers that may be able to expand its presence in the marketplace.
The company’s aim is to bridge the gap between an emergency situation and the arrival of first responders. According to USA Today, this gap is currently an average 6-15 minutes. AEDs address this gap, but oxygen has always been missing. OXYS’ technology is applicable to an alarmingly high population of at-risk individuals:
OXYS’ Model 615 is currently installed internationally in a variety of locations, including:
The company believes that its technology has potential for market placement in:
School Mandates
OXYS believes that there is dire need for mandating emergency oxygen in schools, requiring that an FDA-cleared, non-compressed oxygen source suitable for use by lay rescuers be made widely available.
AEDs are currently mandated in schools in 24 states:
Oxygen administration is often the first requirement in a medical emergency. The standard of care (SOC) today for first responders is to administer oxygen immediately upon arrival. Having an AED nearby would enable nurses, teachers, school administrators, and athletic trainers to “bridge the gap” by applying oxygen sooner, improving medical outcomes and saving lives, as well as minimizing absenteeism and saving millions of dollars for school districts.
Growth Strategy & Sales Model
OXYS’ technologies target a number of enormous end markets. With plans to initially target the 102,265 educational campuses in the U.S., the 350,735 manufacturing facilities, the 350,000 churches, and the 950,000 restaurants, the company could see a relatively large installed base over the near-term.
In the long run, the company aims to place its technology in any public or private place where people are at risk. From recreational vehicles to restaurants to federal buildings, the potential end markets for the Model 615 are at least as numerous as AEDs (2+ million units) and potentially as large as fire extinguishers (100+ million) in the U.S. The markets outside of the U.S. increase the global market size for OXYS to at least 500+ million units.
The company aims to capitalize on these markets primarily through partnerships with distributors and OEM customers. To execute this goal, the company has created a blueprint for growth:
Increase Sales to Existing and New Customers
Introduce New Products / Services and Channels
Pursue Market Catalysts
Marketing support:
Outlook
In the next 3-5 years OXYS aims to add more than 100 new distributors and grow its direct sales force and strategic accounts teams to more than 500 individuals. OXYS also intends to pursue legislation and mandates that would require life-saving devices such as Model 615 in public facilities. In addition, OXYS will:
Management Team
Julian T. Ross, MBA, Chairman & CEO
Julian T. Ross is the OxySure founder, technology developer (holds 9 patents), and CEO. He has more than 25 years of experience in technology, manufacturing, and finance. He has managed development of production capabilities, partnerships and alliances, managed the development of sales, distribution and licensing partnerships, raised in excess of $14 million in debt and equity to fund operations, and took OXYS public in 2011 through an S-1 registration with the Securities and Exchange Commission. Ross’ other experience includes: roll-up, technology companies; $315 million high yield debt offering (Merrill Lynch/Salomon Brothers in lead, plus Deutsche Morgan Grenfell, Nomura Securities).
Jeremy “Jerry” Jones, Director
Jeremy Jones has more than 35 years in healthcare leadership. He was former chairman/CEO of Apria Healthcare (sold to Blackstone for $1.7 billion) and chairman of On Assignment (ASGN), a $1.3 billion healthcare services leader. His current and former boards include: CombiMatrix Corp. (CBMX); Byram Healthcare Centers Inc. (chairman); (3) Lifecare Solutions, Inc. (chairman) (4) US Labs, Inc. (acquired by Lab Corp in 2005; (5) Cardium Healthcare (acquired by CenCorp Health in 2006). He was formerly chairman of the Health Industry Distributors Association (HIDA) and is founding chairman of the Home Oxygen Services Coalition. He has also received the Dr. Jonas Salk Memorial Mentor in Medicine Award from the March of Dimes.
Vicki Jones, MBA, Director
Don Reed, BA, BS – Director
Dr. Vincent Mosesso, Jr., MD, FACEP – Advisory Board
Dr. James R. Winn, MD – Advisory Board
Dr. Thomas D. Franklin, Jr. – Advisory Board
Dr. Jonathan E. Burke, DMD – Advisory Board
Dr. R. Dean White, D.D.S., M.S. – Advisory Board
OxySure Systems, Inc. |
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |